Skip to main content

Table 4 Results of multivariate analysis of overall survival in patients with mCRC

From: Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study

Variables

HR

95%CI

P-value

Gender

1.307

0.932–1.833

0.121

MPV (≥ 9.75 fL versus < 9.75 fL)

1.117

0.752–1.658

0.584

WBC

1.589

1.193–2.116

0.002

ANC

0.679

0.470–0.980

0.038

Hemoglobin (≤120 × 109/L vs.>120 × 109/L)

0.809

0.548–1.193

0.285

PLT

0.995

0.991–1.000

0.038

PCT

2.470

0.237–25.702

0.449

NLR

0.921

0.749–1.132

0.436

PLR

1.007

1.003–1.012

0.002

Efficacy

1.582

1.311–1.909

0.000

  1. All variables with a p-value lower than 0.1 in univariate analysis were included in a multivariate statistical analysis
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us